Acasti Pharma Inc. (ACST) SEC Filing 20-F Annual report for the fiscal year ending Saturday, February 28, 2015

SEC Filings

Acasti Pharma Inc.

CIK: 1444192 Ticker: ACST

View differences made from one year to another to evaluate Acasti Pharma Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 20-F Annual Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Acasti Pharma Inc..


Assess how Acasti Pharma Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Acasti Pharma Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2015 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors


SEC Filing Tools

Material Contracts, Statements, Certifications & more

Acasti Pharma Inc. provided additional information to their SEC Filing as exhibits

Ticker: ACST
CIK: 1444192
Form Type: 20-F Annual Report
Accession Number: 0001171843-15-003461
Submitted to the SEC: Tue Jun 16 2015 5:10:37 PM EST
Accepted by the SEC: Tue Jun 16 2015
Period: Saturday, February 28, 2015
Industry: Pharmaceutical Preparations

External Resources:
Stock Quote
Social Media

Bookmark the Permalink: